Cochlear recently completed an $850mn equity raise via an institutional placement at $140 per share. The capital raise now removes any balance sheet concerns.
Following the placement, we estimate COH will have total liquidity of
$1.0bn+ with little in the way of debt maturities until 2022.
You're not a member! Trial today
The pathway back to elective surgery appears to be improving and we, therefore, see the current price range as an opportunity to accumulate COH shares.
